Novel insights into the apoptosis mechanism of DNA topoisomerase I inhibitor isoliquiritigenin on HCC tumor cell

Biochemical and Biophysical Research Communications

Volumn 464, Issue 2, 2015, Pages 548-553

  Li, Ze Xin ^a   Li, Jian ^a   Li, Yan ^a   You, Kun ^a   Xu, Hongwei ^a   Wang, Jianguo ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis cells; DNA topoisomerase I; Fluorescence quenching; Inhibition effect; Isoliquiritigenin; Melting measurements; Molecular simulation

Indexed keywords

ISOLIQUIRITIGENIN; CHALCONE DERIVATIVE; DNA; DNA TOPOISOMERASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA HELIX; DNA SUPERCOILING; DRUG MECHANISM; ENTHALPY; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; MOLECULAR DOCKING; PRIORITY JOURNAL; TUMOR CELL LINE; CHEMISTRY; DRUG EFFECTS;

APOPTOSIS; CELL LINE, TUMOR; CHALCONES; DNA; HUMANS; MOLECULAR DOCKING SIMULATION; TOPOISOMERASE I INHIBITORS;

EID: 84938401461     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.07.003     Document Type: Article

References (35)

1. Y. Pommier DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition Chem. Rev. 109 2009 2894 2902
2. Y. Pommier Topoisomerase I inhibitors: camptothecins and beyond Nat. Rev. Cancer 6 2006 789 802
3. J.J. Champoux DNA topoisomerases: structure, function, and mechanism Ann. Rev. Biochem. 70 2001 369 413
4. L. Stewart, M.R. Redinbo, X. Qiu, W.G.J. Hol, and J.J. Champoux A model for the mechanism of human topoisomerase I Science 279 1998 1534 1541
5. Y. Pommier, J.A. Barcelo, V.A. Rao, O. Sordet, A.G. Jobson, L. Thibaut, Z.H. Miao, J.A. Seiler, H. Zhang, C. Marchand, K. Agama, and C. Redon Repair of topoisomerase I-mediated DNA damage Prog. Nucl. Acid Res. Mol. Biol. 81 2006 179 229
6. O. Sordet, Q.A. Khan, K.W. Kohn, and Y. Pommier Apoptosis induced by topoisomerase inhibitors Curr. Med. Chem. Anti Cancer Agents 3 2003 271 290
7. B.L. Staker, K. Hjerrild, M.D. Feese, C.A. Behnke, A.B. Burgin, and L. Stewart The mechanism of topoisomerase I poisoning by a camptothecin analogue Proc. Natl. Acad. Sci. U. S. A. 99 2002 15387 15392
8. J.C. Wang Cellular roles of DNA topoisomerases: a molecular perspective Nat. Rev. Mol. Cell. Biol. 3 2002 430 440
9. M.E. Wall, M.C. Wani, C.E. Cook, K.H. Palmer, A.T. McPhail, and G.A. Sim Plant antitumor agents. I. The isolation and structure of camptothecin, a novel Alkaloidal Leukemia and tumor inhibitor from camptotheca acuminata J. Am. Chem. Soc. 88 1966 3888 3890
10. B. Teicher Next generation of topoisomerase I inhibitors: rationale and biomarker strategies Biochem. Pharmacol. 75 2008 1262 1271
11. C.J. Thomas, N.J. Rahier, and S.M. Hecht Camptothecin: current perspectives Bioorg. Med. Chem. 12 2004 1585 1604
12. C.J. Li, L. Averboukh, and A.B. Pardee Beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin J. Biol. Chem. 268 1993 22463 22468
13. C. Jaxel, K.W. Kohn, M.C. Wani, and Y. Pommier Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity Cancer Res. 49 1989 1465 1469
14. H. Minami, J.H. Beijen, J. Verwij, and M.J. Ratain Limited sampling model for area under the concentration time curve of total Topotecan Clin. Cancer Res. 2 1996 43 46
15. M.J. Luzzio, J.M. Besterman, D.L. Emerson, M.G. Evans, K. Lackey, P.L. Leitner, G. McIntyre, B. Morton, P.L. Myers, and et al. Synthesis and antitumor-activity of novel water-soluble derivatives of camptothecin as specific inhibitors of topoisomerase-I J. Med. Chem. 38 1995 395 401
16. Z. Mi, and T.G. Burke Differential interactions of camptothecin lactone and carboxylate forms with human blood components Biochemistry 33 1994 10325 10336
17. Y. Urasaki, G.S. Laco, P. Pourquier, Y. Takebayashi, G. Kohlhagen, C. Gioffre, H.L. Zhang, D. Chatterjee, P. Pantazis, and Y. Pommier Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line Cancer Res. 61 2001 1964 1969
18. A. Fujimori, W.G. Harker, G. Kohlhagen, Y. Hoki, and Y. Pommier Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell resistant to camptothecin Cancer Res. 55 1995 1339 1346
19. S.E. Bates, W.Y. Medina-Perez, G. Kohlhagen, S. Antony, T. Nadjem, R.W. Robey, and Y. Pommier ABCG2 mediates differential resistance to SN-38 (7-Ethyl-10-hydroxycamptothecin) and homocamptothecins J. Pharmacol. Exp. Ther. 310 2004 836 842
20. Y. Hoki, A. Fujimori, and Y. Pommier Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein overexpressing cell lines Cancer Chemother. Pharmacol. 40 1997 433 438
21. M. Brangi, T. Litman, M. Ciotti, K. Nishiyama, G. Kohlhagen, C. Takimoto, R. Robey, Y. Pommier, T. Fojo, and S.E. Bates Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing Cells Cancer Res. 59 1999 5938 5946
22. D.K. Armstrong Topotecan dosing guidelines in ovarian cancer: reduction and management of hematologic toxicity Oncologist 9 2004 33 42
23. L.B. Saltz Clinical use of irinotecan: current status and future considerations Oncologist 2 1997 402 409
24. S.Y. Bi, Y.T. Sun, C.Y. Qiao, H.Q. Zhang, and C.M. Liu Binding of several anti-tumor drugs to bovine serum albumin: fluorescence study J. Lumin 129 2009 541 547
25. Y.Q. Li, F.C. Zhou, F. Gao, J.S. Bian, and F. Shan Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase J. Agric. Food Chem. 57 2009 11463 11468
26. G.W. Zhang, L. Wang, and J.H. Pan Probing the binding of the flavonoid diosmetin to human serum albumin by multispectroscopic techniques J. Agric. Food Chem. 60 2012 2721 2729
27. M. Liu, W. Zhang, L. Qiu, and X.K. Lin Synthesis of butyl-isobutyl-phthalate and its interaction with α-glucosidase in vitro J. Biochem. 149 2011 27 33
28. A.A. Godbole, M.N. Leelaram, A.G. Bhat, P. Jain, and V. Nagaraja Characterization of DNA topoisomerase I from mycobacterium tuberculosis: DNA cleavage and relegation properties and inhibition of its activity Arch. Biochem. Biophys. 528 2012 197 203
29. H.M. Berman, J. Westbrook, Z.K. Feng, G. Gilliland, T.N. Bhat, H. Weissig, L.N. Shindyalov, and P.E. Bourne The protein data bank Nucl. Acid Res. 28 2000 235 242
30. C.G. Ricci, and P.A. Netz Docking studies on DNA-ligand interactions: building and application of a protocol to identify the binding mode J. Chem. Inf. Model 49 2009 1925 1935
31. H. Zhang, R.T. Liu, Z.X. Chi, and C.Z. Gao Toxic effects of different charged metal ions on the target-Bovine serum albumin Spectrochim. Acta Part A 78 2011 523 527
32. G.W. Zhang, Y.D. Ma, L. Wang, Y.P. Zhang, and J. Zhou Multispectroscopic studies on the interaction of maltol, a food additive, with bovine serum albumin Food Chem. 133 2012 264 270
33. P.D. Ross, and S. Subramanian Thermodynamics of protein association reactions: forces contributing to stability Biochemistry 20 1981 3096 3102
34. Y.D. Ma, G.W. Zhang, and J.H. Pan Spectroscopic studies of DNA interaction with food colorant indigo carmine with the use of ethidium bromide as a fluorescence probe J. Agric. Food Chem. 60 2012 10867 10875
35. Y.T. Sun, H.Q. Zhang, S.Y. Bi, X.F. Zhou, L. Wang, and Y.S. Yan Studies on the arctilin and its interaction with DNA by spectral methods J. Lumin. 131 2011 2299 2306